Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss Nanotech Investing
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week Nanotech Investing
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights Nanotech Investing
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress Nanotech Investing
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 Nanotech Investing
Group Financial Results as of March 31st 2024 Approved, Continued Growth and EBITDA Margin Expansion, Euro 500 Million Share Buy-Back Program Launched Nanotech Investing
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer Nanotech Investing
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update Nanotech Investing
